These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7025372)

  • 1. Nature of autolymphocytotoxins present in renal hemodialysis patients. Their possible role in controlling alloantibody formation.
    Lobo PI
    Transplantation; 1981 Sep; 32(3):233-7. PubMed ID: 7025372
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiidiotypic activity in sera from sensitised potential transplant recipients.
    al Muzairai IA; MacLeod AM; Innes A; Cunningham C; Stewart KN; Power DA; Catto GR
    Nephrol Dial Transplant; 1988; 3(6):803-8. PubMed ID: 3147424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood serum immunoglobulin level in chronic renal insufficiency treated by hemodialysis].
    Gagarinova AV; Chernyshov VP
    Urol Nefrol (Mosk); 1980; (1):58-60. PubMed ID: 7368442
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cold lymphocytotoxins and their role during kidney transplantation].
    Donskov SI; Manishkina RP; Krasavtseva TK; Belorusov OS; Tsygankova ST
    Probl Gematol Pereliv Krovi; 1982 Apr; 27(4):30-5. PubMed ID: 7048289
    [No Abstract]   [Full Text] [Related]  

  • 5. Serologic considerations in donor-specific transfusion therapy for kidney transplantation.
    Schweizer R; Bow L; Generas D; Bartus S
    Transplant Proc; 1982 Jun; 14(2):374-7. PubMed ID: 6810522
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of dithiothreitol on a variety of evolutive patterns of anti-T and -B lymphocyte antibodies in renal transplant candidates.
    García de Masdevall MD; Arrieta A; Riñón M; Altés C; Arranz C
    Transplant Proc; 1992 Dec; 24(6):2505-7. PubMed ID: 1465847
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics and clinical relevance of autolymphocytotoxins in patients with aplastic anemia.
    Carpentier N; Fontannaz J; Jeannet M; Nissen C; Speck B
    Transplantation; 1986 Aug; 42(2):159-61. PubMed ID: 3526656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to donor B lymphocytes and autoantibodies in renal transplantation.
    Ettenger RB; Robinson BJ; Uittenbogaart CH; Hacker TA; Pennisi AJ; Malekzadeh MH; Fine RN
    Transplant Proc; 1979 Mar; 11(1):401-3. PubMed ID: 377666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of repeated transfusions and cyclosporine on secondary alloantibody responses in inbred rats.
    Jones MC; Power DA; Cunningham C; Catto GR
    Transplantation; 1988 Jun; 45(6):1094-9. PubMed ID: 3260048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet, granulocyte, and HLA antibodies in renal dialysis patients transfused with frozen blood.
    Minchinton RM; Waters AH; Baker LR; Cattell WR
    Br Med J; 1980 Jul; 281(6233):113-4. PubMed ID: 7427203
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity of serum HLA antigens in allogeneic combinations.
    Pellegrino MA; Indiveri F; Fagiolo U; Antonello A; Ferrone S
    Transplantation; 1982 May; 33(5):530-3. PubMed ID: 6953687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
    Wasowska B; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor bone marrow infusion suppresses alloantibody response in RATG-treated recipients: a correlate of long survival.
    Thomas JM; Carver FM; Cunningham PR; Gross U; Verbanac KM; Rebellato LM; Riley R; Thomas FT
    Transplant Proc; 1993 Feb; 25(1 Pt 1):342-3. PubMed ID: 8438326
    [No Abstract]   [Full Text] [Related]  

  • 14. [Monthly changes in serum alpha 2-globulin and immunoglobulin levels in chronic hemodialysis patients--with special reference to the occurrence of cancer and blood transfusion].
    Misao A; Saji S; Hosono Y; Takekoshi T; Tanaka S; Sato Y; Mori N; Yasui S; Kuriyama I
    Gan No Rinsho; 1985 Jul; 31(8):953-8. PubMed ID: 2411969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic anemia with IgG and IgM autoantibodies and allontibodies.
    Crookston JH
    Arch Intern Med; 1975 Oct; 135(10):1314-5. PubMed ID: 1174300
    [No Abstract]   [Full Text] [Related]  

  • 16. [Presence of Australia antigen, histocompatibility (HL-A) antigens, and autolymphocytotoxins (CoCoCy) during different forms of hepatitis and cirrhosis].
    Bertrams J; Kuwert E; Reis HE; Selmair H; Wiese W
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):372-7. PubMed ID: 4154614
    [No Abstract]   [Full Text] [Related]  

  • 17. Autolymphocytotoxic antibodies in patients on dialysis awaiting renal transplantation.
    Ettenger RB; Jordan S; Fine RN
    Transplantation; 1981 Sep; 32(3):248-51. PubMed ID: 7025374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytic IgM antibody in highly sensitized (greater than 50% PRA) autologous negative renal allograft candidates.
    Shroyer TW; Diethelm AG; Deierhoi MH; Barber WH; Barger BO
    Transplant Proc; 1989 Feb; 21(1 Pt 1):739-41. PubMed ID: 2650250
    [No Abstract]   [Full Text] [Related]  

  • 19. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion.
    Wray DW; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM antibodies in renal transplantation.
    McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
    Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.